Feasibility and efficacy of salvage lung resection after definitive chemoradiation therapy for Stage III non-small-cell lung cancer.
暂无分享,去创建一个
Kenji Suzuki | M. Tsuboi | M. Okada | Y. Shimada | H. Saji | N. Ikeda | T. Mitsudomi | T. Mimae | K. Takamochi | K. Aokage | H. Nakayama | Y. Kudo | Aritoshi Hattori | T. Nishii | H. Ito
[1] M. Berry,et al. Long-Term Outcomes of Lobectomy for Non-Small Cell Lung Cancer After Definitive Radiation Treatment. , 2015, The Annals of thoracic surgery.
[2] L. Freitag,et al. Prognostic model for long-term survival of locally advanced non-small-cell lung cancer patients after neoadjuvant radiochemotherapy and resection integrating clinical and histopathologic factors , 2015, BMC Cancer.
[3] W. Curran,et al. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study. , 2015, The Lancet. Oncology.
[4] D. Boffa,et al. Pulmonary resections following prior definitive chemoradiation therapy are associated with acceptable survival. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[5] A. Chang,et al. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. , 2013, Chest.
[6] G. Michaud,et al. Treatment of stage III non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. , 2013, Chest.
[7] A. Yoshizawa,et al. Salvage Lung Resection for Non-small Cell Lung Cancer After Stereotactic Body Radiotherapy in Initially Operable Patients , 2010, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[8] M. Tsuboi,et al. Salvage surgery for advanced non-small cell lung cancer after response to gefitinib. , 2010, The Journal of thoracic and cardiovascular surgery.
[9] M. Suntharalingam,et al. Pneumonectomy for lung cancer after preoperative concurrent chemotherapy and high-dose radiation. , 2010, The Annals of thoracic surgery.
[10] L. Schwartz,et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). , 2009, European journal of cancer.
[11] D. Wood,et al. Salvage lung resection after definitive radiation (>59 Gy) for non-small cell lung cancer: surgical and oncologic outcomes. , 2008, The Annals of thoracic surgery.
[12] R. Shemin,et al. Pneumonectomy after high-dose radiation and concurrent chemotherapy for nonsmall cell lung cancer. , 2006, The Annals of thoracic surgery.
[13] J. Daurès,et al. Randomized phase III trial of sequential chemoradiotherapy compared with concurrent chemoradiotherapy in locally advanced non-small-cell lung cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique-Groupe Français de Pneumo-Cancérologie NPC 95-01 Study. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] K. Schulmann,et al. Tumour regression in non-small-cell lung cancer following neoadjuvant therapy. Histological assessment , 2005, Journal of Cancer Research and Clinical Oncology.
[15] M. Suntharalingam,et al. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer. , 2004, The Annals of thoracic surgery.
[16] W. Richards,et al. Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival. , 2000, The Annals of thoracic surgery.
[17] Richard A. Szucs,et al. TNM Classification of Malignant Tumors. 5th ed , 1998 .
[18] J. Crowley,et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. , 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] W. Curran,et al. Postoperative complications after combined neoadjuvant treatment of lung cancer. , 1993, The Annals of thoracic surgery.
[20] R. Ginsberg,et al. Is there ever a role for salvage operations in limited small-cell lung cancer? , 1991, The Journal of thoracic and cardiovascular surgery.
[21] L. Sobin,et al. TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.